Stay updated on Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:52:39.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. This appears to be a metadata/version update and does not change study content or eligibility information.
    Difference
    0.1%
    Check dated 2026-03-20T06:53:38.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This update reflects a metadata revision on the page and does not modify study details or eligibility.
    Difference
    0.1%
    Check dated 2026-03-05T19:37:31.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2 without changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:30:45.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1; this appears to be a minor metadata update with no changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:53:25.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a glossary toggle and QC-related metadata labels (Last Update Submitted that Met QC Criteria) along with a revision tag (Revision: v3.4.0). These are UI/metadata updates rather than changes to core study content.
    Difference
    0.2%
    Check dated 2026-01-28T20:28:12.000Z thumbnail image

Stay in the know with updates to Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.